Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04768036 · ClinicalTrials.gov registry record · NA
A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 10,699
- Enrollment target
NCT04768036: Completed NA study, sponsored by Northwell Health.
NCT04768036 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 10,699 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (663% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04768036, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,699 participants
- Enrollment target
Study Summary
This study will be a multicenter clustered randomized trial of patients in hospitals in which a universal "SMART on FHIR" platform-based EHR-embedded IMPROVE DD VTE clinical prediction rules (CPRs) with electronic order entry has been incorporated into required admission and discharge EHR workflow versus hospitals following UMC for VTE risk assessment of medically ill patients. The patient population will consist of hospitalized, medically ill (non-surgical, non-obstetrical) individuals aged \> 60 years.
Primary Outcome
Specifically, our pilot study will determine if this QI intervention will result in a greater increase in the proportion of at-VTE or high-VTE risk medical patients that are treated with an appropriate thromboprophylactic agent, both during hospitalization and in the post-hospital discharge period using a 5-point score where 0-1 constitutes low VTE risk, 2-3 constitutes moderate VTE risk, and 4 constitutes high VTE risk.
Interventions
- OTHER IMPROVE DD VTE Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,699 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2022-01-21 |
| Phase | NA |
What the finished NCT04768036 record still lists
NCT04768036 is an interventional study that assigns participants to a tested intervention. Its 10,699 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (663% higher).
The record links to 0 conditions, and to 1 intervention - of which IMPROVE DD VTE Tool is the first listed.
NCT04768036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04768036 about?
NCT04768036 is a clinical study titled "A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients". This study will be a multicenter clustered randomized trial of patients in hospitals in which a universal "SMART on FHIR" platform-based EHR-embedded IMPROVE DD VTE clinical prediction rules (CPRs) with electronic order entry has been incorporated into required admission and discharge EHR workflow v...
What is the current status of trial NCT04768036?
This trial is currently completed. It is a NA study. The enrollment target is 10,699 participants. The study started on 2020-12-21. Estimated completion is 2022-01-21.
What interventions are being tested in trial NCT04768036?
The interventions under investigation include: IMPROVE DD VTE Tool (OTHER).
Who is sponsoring clinical trial NCT04768036?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04768036's enrollment target sits among peer trials
10,699 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI